Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Morten A. Karsdal »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Morry Silberstein < Morten A. Karsdal < Morten A. Nielsen  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000E73 (2016) Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Anne Sofie Siebuhr [Danemark] ; Claus Christiansen [Danemark] ; Inger Byrjalsen [Danemark] ; Morten A. Karsdal [Danemark]Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study.
001290 (2014) Anne C. Bay-Jensen [Royaume-Uni] ; Inger Byrjalsen ; Anne Sofie Siebuhr ; Claus Christiansen ; Adam Platt ; Morten A. KarsdalSerological biomarkers of joint tissue turnover predict tocilizumab response at baseline.
001375 (2014) Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Inger Byrjalsen [Danemark] ; Philippe Vergnoud [France] ; Claus Christiansen [Danemark] ; Morten A. Karsdal [Danemark]Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study.
001514 (2013) Anne Sofie Siebuhr ; Anne C. Bay-Jensen ; Diana J. Leeming ; Adam Plat ; Inger Byrjalsen ; Claus Christiansen ; Désirée Van De Heijde ; Morten A. KarsdalSerological identification of fast progressors of structural damage with rheumatoid arthritis.
001765 (2012) Morten A. Karsdal [Danemark] ; Georg Schett ; Paul Emery ; Olivier Harari ; Inger Byrjalsen ; Andy Kenwright ; Anne C. Bay-Jensen ; Adam PlattIL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
001C78 (????) Pernille Juhl [Danemark] ; Christian S. Thudium [Danemark] ; Natasja S. Gudmann [Danemark] ; Morten A. Karsdal [Danemark] ; Anne-Christine Bay-Jensen [Danemark] ; Anne Sofie Siebuhr [Danemark]IL-6 receptor inhibition modulates type III collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Morten A. Karsdal" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Morten A. Karsdal" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Morten A. Karsdal
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021